Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group Plc (AMS.L) on 28th July 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc acted in a client-serving capacity during the dealings, and holds the position of Advisor and Joint Broker to Advanced Medical Solutions Group Plc.
The filing confirms that Investec purchased a total of 1,000,509 ordinary shares in Advanced Medical Solutions Group on the dealing date.
Those purchases were executed at prices ranging from a low of 280 pence per unit to a high of 280.1 pence per unit.
On the same date, Investec also sold 1,034,688 ordinary shares in the company, representing a slightly larger volume than the purchases made.
The sales were conducted at prices ranging from 280 pence per unit at the lowest to 280.25 pence per unit at the highest.
The narrow spread between buying and selling prices indicates the dealings took place within a tight and relatively stable market range for the stock.
Investec confirmed there are no indemnity arrangements, options, or other agreements that could serve as an inducement to deal or refrain from dealing in the relevant securities.
The bank also confirmed no agreements or understandings exist relating to voting rights, future acquisitions, or disposals connected to any derivative referencing the securities.
The disclosure was submitted on 29th July 2026, with contact for the filing attributed to Priyali Bhattacharjee.
Such filings are a routine regulatory requirement during offer periods, ensuring transparency in dealings by parties connected to a transaction under the UK Takeover Code.
